Stockscreener 앱 받기
41.23
4.78%
1.88
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
PROCEPT BioRobotics Corporation Attempts Reversal From Key SupportJuly 2025 Update & Fast Entry and Exit Trade Plans - classian.co.kr
PROCEPT BioRobotics Independent Director Acquires 2.4% More Stock - 富途牛牛
Overvalued Healthcare Tech Stocks: How Predictive Models Can Anticipate Market Corrections—A Case Study of PROCEPT BioRobotics (PRCT) - AInvest
Why PROCEPT BioRobotics (PRCT) Is Up 8.3% After Raising 2025 Revenue Guidance - simplywall.st
PROCEPT BioRobotics Corporation Shows Risk Reward Favoring Upside2025 Year in Review & Accurate Entry and Exit Point Alerts - 선데이타임즈
Why PROCEPT BioRobotics Corporation stock attracts strong analyst attentionAnalyst Upgrade & Entry and Exit Point Strategies - sundaytimes.kr
Director’s Bold Move: Major Investment in PROCEPT BioRobotics - TipRanks
Procept BioRobotics: A High-Growth Buy with Strengthening Pricing Power and Global Expansion Momentum - AInvest
Procept BioRobotics: Boosting Average Selling Price, Initiates Buy Rating - AInvest
Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy (NASDAQ:PRCT) - Seeking Alpha
PROCEPT BioRobotics 15min chart: RSI Oversold, KDJ Golden Cross detected. - AInvest
Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT) - MSN
PROCEPT BioRobotics (PRCT) Guides Higher on Q2 Revenue Beat and Narrowing Losses – What Signals Ahead? - simplywall.st
Procept BioRobotics Grows Fast Despite Wall Street Skepticism - Finimize
PROCEPT BioRobotics Reports Strong Q2 2025 Growth - TipRanks
Why PROCEPT BioRobotics Shares Are Tumbling - TipRanks
Procept Biorobotics Reports Strong Q2 Growth Amid Challenges - TipRanks
PROCEPT BioRobotics outlines $325.5M 2025 revenue target amid leadership transition and margin expansion - MSN
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Call Transcript - MSN
What You Can Learn From PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S After Its 34% Share Price Crash - simplywall.st
Procept Biorobotics Corp.’s Aquablation Therapy: A Promising Update for Prostate Cancer Treatment - The Globe and Mail
Edwards’ Longtime TAVR Leader is Named PROCEPT BioRobotics CEO - Medical Product Outsourcing
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $55 to $83 - 富途牛牛
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$65.75 Price Target - simplywall.st
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Qiagen (QGEN) - The Globe and Mail
PROCEPT BioRobotics 2025 Q2 Earnings Improved Losses Amid Revenue Surge - AInvest
PROCEPT BioRobotics Posts Q2 2025 Earnings: Revenue Up 48%, Net Loss Narrows by 24% - AInvest
PROCEPT BioRobotics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Buy Rating for PROCEPT BioRobotics: Growth Potential and Stability Amid Sales Beat and Improved Guidance - TipRanks
Procept BioRobotics' Q2 Revenue Jumps 48%, Exceeds Estimates - AInvest
PROCEPT BioRobotics Reports 48% YoY Revenue Growth in Q2 2025 - AInvest
Procept Biorobotics shares fall 13.46% intraday despite increased revenue guidance for 2025. - AInvest
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $85 to $85 - 富途牛牛
Earnings call transcript: Procept BioRobotics Q2 2025 beats forecasts, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Procept BioRobotics Q2 2025 beats forecasts, stock dips - Investing.com
Truist Lowers Price Target on PROCEPT BioRobotics to $64 From $70, Keeps Buy Rating - MarketScreener
Wells Fargo lowers Procept BioRobotics stock price target on delayed system replacements - Investing.com Canada
Optimistic Outlook on PROCEPT BioRobotics Amidst Medtech Sector Challenges - TipRanks
PROCEPT BioRobotics (PRCT): Assessing the Path to Profitability Amid Leadership Transition and Global Expansion - AInvest
PROCEPT BioRobotics Sets $325.5M 2025 Revenue Target Amid Leadership Change and Margin Expansion - AInvest
Transcript : PROCEPT BioRobotics Corporation, Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Procept (PRCT) Q2 Revenue Jumps 48% - The Globe and Mail
Procept (PRCT) Q2 Revenue Jumps 48% - The Motley Fool
PROCEPT BioRobotics (PRCT) Earnings Transcript - Mitrade
Procept Biorobotics shares fall 3.72% after-hours despite Q2 revenue up 48% and raised 2025 guidance. - AInvest
Procept Biorobotics earnings beat by $0.06, revenue topped estimates - Investing.com South Africa
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7% - AOL.com
PROCEPT BioRobotics Q2 revenue up 48% YoY to $79.2mln. - AInvest
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results - TradingView
0.89%
자본화:
|
볼륨(24시간):